chr8-144360710-C-T
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001363118.2(SLC52A2):c.1122C>T(p.Leu374Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000636 in 1,565,694 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001363118.2 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC52A2 | NM_001363118.2 | c.1122C>T | p.Leu374Leu | synonymous_variant | Exon 4 of 5 | ENST00000643944.2 | NP_001350047.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000663 AC: 96AN: 144896Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000657 AC: 157AN: 238862Hom.: 0 AF XY: 0.000607 AC XY: 79AN XY: 130054
GnomAD4 exome AF: 0.000633 AC: 899AN: 1420798Hom.: 2 Cov.: 42 AF XY: 0.000665 AC XY: 469AN XY: 705776
GnomAD4 genome AF: 0.000663 AC: 96AN: 144896Hom.: 0 Cov.: 33 AF XY: 0.000639 AC XY: 45AN XY: 70406
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
SLC52A2: BP4 -
- -
- -
not specified Benign:1
p.Leu374Leu in exon 4 of SLC52A2: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 0.12% (76/63972) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs144290224). -
SLC52A2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Brown-Vialetto-van Laere syndrome 2 Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at